Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapid

Urgent suspected breast-cancer referral

Essential points for quick revision.

Saved on this device

Synopsis

Develop the ability to apply current NICE suspected-cancer referral criteria accurately, communicate the reason without implying a diagnosis and safety-net symptoms that fall outside automatic thresholds, while explaining uncertainty and arranging reliable review.

  • Refer through the suspected-cancer pathway when a person aged 30 or over has an unexplained breast lump, whether painful or painless.
  • Refer a person aged 50 or over for unilateral nipple discharge, retraction or another concerning nipple change under the NICE breast recommendation.
  • Consider the suspected-cancer pathway at any age for skin changes suggesting breast cancer; NG12 does not attach an age threshold to this indication.

Reasoning priorities

01
Focused referral history

Establish whether the feature is unexplained and matches a current criterion.

Record age, duration, laterality, pain, nipple and skin changes, pregnancy or lactation, infection features and prior imaging so triage can understand the concern.

Worked reasoning

Worked case: integrated breast assessmentApply urgent suspected breast-cancer referral to a defined presentation

A 33-year-old presents with a new unexplained painless breast lump. They ask whether lack of pain means it can safely be reviewed after several months.

  1. Take a targeted history and examine the breasts and nodes, documenting the lump site and any skin, nipple or systemic features that could affect triage.
  2. Match the case to NG12: age 30 or over with an unexplained breast lump qualifies for a suspected-cancer pathway referral with or without pain.
  3. Explain the referral in neutral terms, including that most assessed symptoms are not cancer but timely triple assessment is needed to establish the diagnosis.
  4. Send a complete referral containing relevant history, examination, accessibility and communication needs, and provide written information about the expected process.
  5. Verify electronic acceptance and appointment arrangements; safety-net rapid growth, new erythema, skin distortion, nipple bleeding or systemic deterioration.
Open full textbook Answer 2 questions
Sources and review status3 sources · checked 7 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 7 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom